D. Verver

786 total citations
26 papers, 479 citations indexed

About

D. Verver is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, D. Verver has authored 26 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 10 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in D. Verver's work include Cutaneous Melanoma Detection and Management (17 papers), Melanoma and MAPK Pathways (8 papers) and Nonmelanoma Skin Cancer Studies (8 papers). D. Verver is often cited by papers focused on Cutaneous Melanoma Detection and Management (17 papers), Melanoma and MAPK Pathways (8 papers) and Nonmelanoma Skin Cancer Studies (8 papers). D. Verver collaborates with scholars based in Netherlands, Germany and France. D. Verver's co-authors include Cornelis Verhoef, Dirk J. Grünhagen, Alexander C. J. van Akkooi, Astrid A.M. van der Veldt, Shiromani Janki, Jan N.M. IJzermans, Rudolf Stadler, Ulrike Leiter, Claus Garbe and Werner Hohenberger and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.

In The Last Decade

D. Verver

24 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Verver Netherlands	12	355	148	146	63	62	26	479
Damian Silbermins United States	6	338 1.0×	82 0.6×	116 0.8×	154 2.4×	73 1.2×	8	529
Melanie Warycha United States	11	311 0.9×	166 1.1×	136 0.9×	48 0.8×	20 0.3×	21	541
Cynthia Heffron Ireland	12	207 0.6×	198 1.3×	220 1.5×	205 3.3×	44 0.7×	34	619
Séamus S. Napier United Kingdom	8	118 0.3×	106 0.7×	48 0.3×	155 2.5×	44 0.7×	14	666
A. Schoengen Germany	12	557 1.6×	160 1.1×	227 1.6×	50 0.8×	30 0.5×	44	661
Samuel Bieligk United States	11	312 0.9×	53 0.4×	120 0.8×	108 1.7×	53 0.9×	13	473
Larsolof Hafström Sweden	8	227 0.6×	167 1.1×	59 0.4×	117 1.9×	179 2.9×	15	552
Elisabeth Hardy France	7	299 0.8×	163 1.1×	55 0.4×	27 0.4×	35 0.6×	10	470
Francesca Pagliuca Italy	12	132 0.4×	64 0.4×	48 0.3×	112 1.8×	67 1.1×	42	357
Giulia Veronesi Italy	11	186 0.5×	122 0.8×	60 0.4×	66 1.0×	61 1.0×	58	367

Countries citing papers authored by D. Verver

Since Specialization

Citations

This map shows the geographic impact of D. Verver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Verver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Verver more than expected).

Fields of papers citing papers by D. Verver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Verver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Verver. The network helps show where D. Verver may publish in the future.

Co-authorship network of co-authors of D. Verver

This figure shows the co-authorship network connecting the top 25 collaborators of D. Verver. A scholar is included among the top collaborators of D. Verver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Verver. D. Verver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wakkee, Marlies, Margot Joosen, D. Verver, et al.. (2024). “There is a life before and after cancer”: experiences of resuming life and unmet care needs in stage I and II melanoma survivors. Archives of Dermatological Research. 316(9). 645–645.

Mulder, Evalyn E.A.P., Iva Johansson, Dirk J. Grünhagen, et al.. (2023). Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I-II melanoma patients at risk for disease relapse. European Journal of Surgical Oncology. 49(2). e33–e34. 1 indexed citations

Birnie, Erwin, et al.. (2023). Implementation of vacuum-assisted excision as a management option for benign and high-risk breast lesions. British Journal of Radiology. 96(1147). 20220776–20220776. 6 indexed citations

Mulder, Evalyn E.A.P., Jeffrey Damman, D. Verver, et al.. (2022). Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma. Melanoma Research. 32(4). 249–259. 2 indexed citations

Mulder, Evalyn E.A.P., D. Verver, Thierry P. P. van den Bosch, et al.. (2022). Mesenchymal-epithelial transition factor (MET) immunoreactivity in positive sentinel nodes from patients with melanoma. Annals of Diagnostic Pathology. 58. 151909–151909. 1 indexed citations

Verseveld, M., D. Verver, Bo Jan Noordman, et al.. (2021). Treatment of clinical T1 rectal cancer in the Netherlands; a population-based overview of clinical practice. European Journal of Surgical Oncology. 48(5). 1153–1160. 4 indexed citations

Verver, D., Vincent van der Noort, Dirk J. Grünhagen, et al.. (2021). Therapeutic neck dissection in head and neck melanoma patients: Comparing extent of surgery and clinical outcome in two cohorts. European Journal of Surgical Oncology. 47(9). 2454–2459. 1 indexed citations

Mulder, Evalyn E.A.P., D. Verver, Lukas B. Been, et al.. (2021). False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T‐VEC). Journal of Surgical Oncology. 124(7). 1161–1165. 1 indexed citations

Verver, D., Dirk J. Grünhagen, Alexander C. J. van Akkooi, et al.. (2021). Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy. Cancer Immunology Immunotherapy. 70(11). 3123–3135. 7 indexed citations

10.

Deken, Marion M., Helena C. van Doorn, D. Verver, et al.. (2020). Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer – a randomized controlled trial. Gynecologic Oncology. 159(3). 672–680. 27 indexed citations

11.

Verver, D., Claus Garbe, David van Klaveren, et al.. (2020). The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node–positive melanoma without the need for completion lymph node dissection. European Journal of Cancer. 134. 9–18. 13 indexed citations

12.

Leiter, Ulrike, Rudolf Stadler, Cornelia Mauch, et al.. (2019). Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node. Journal of Clinical Oncology. 37(32). 3000–3008. 138 indexed citations

13.

Mulder, Evalyn E.A.P., Jvalini Dwarkasing, Loes M. Hollestein, et al.. (2019). Validation of a clinicopathological and gene expression profile (CP-GEP) model for sentinel lymph node metastasis in primary cutaneous melanoma. Annals of Oncology. 30. v540–v540. 5 indexed citations

14.

Verver, D., Linetta B. Koppert, Cecile de Monyé, et al.. (2018). Gamma probe and ultrasound-guided fine needle aspiration cytology of the sentinel node (GULF) trial. European Journal of Nuclear Medicine and Molecular Imaging. 45(11). 1926–1933. 6 indexed citations

15.

Verver, D., David van Klaveren, Alexander C. J. van Akkooi, et al.. (2018). Risk stratification of sentinel node–positive melanoma patients defines surgical management and adjuvant therapy treatment considerations. European Journal of Cancer. 96. 25–33. 43 indexed citations

16.

Verver, D., David van Klaveren, Viola Franke, et al.. (2018). Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes. British journal of surgery. 106(3). 217–225. 24 indexed citations

17.

Verver, D., Marieke W.J. Louwman, Senada Koljenović, et al.. (2017). Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study. European Journal of Cancer. 92. 100–107. 8 indexed citations

18.

Schep, Niels W. L., et al.. (2017). Treatment of extra-articular proximal and middle phalangeal fractures of the hand: a systematic review. Strategies in Trauma and Limb Reconstruction. 12(2). 63–76. 23 indexed citations

19.

Klompenhouwer, Anne J., D. Verver, Shiromani Janki, et al.. (2017). Management of hepatic angiomyolipoma: A systematic review. Liver International. 37(9). 1272–1280. 51 indexed citations

20.

Janki, Shiromani, D. Verver, Karel W.J. Klop, et al.. (2015). Vascular Management During Live Donor Nephrectomy: An Online Survey Among Transplant Surgeons. American Journal of Transplantation. 15(6). 1701–1707. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact